NCT01078337

Brief Summary

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2002

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 2, 2010

Completed
Last Updated

March 2, 2010

Status Verified

February 1, 2010

Enrollment Period

4.9 years

First QC Date

February 26, 2010

Last Update Submit

March 1, 2010

Conditions

Leukemia, Lymphocytic, Acute

Interventions

bone marrow aspirationPROCEDURE
peripheral blood samplingPROCEDURE

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children with newly diagnosed T-cell ALL

You may qualify if:

  • Children with newly diagnosed T-cell ALL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood and bone marrow

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Gary V Dahl

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 26, 2010

First Posted

March 2, 2010

Study Start

November 1, 2002

Primary Completion

October 1, 2007

Study Completion

October 1, 2007

Last Updated

March 2, 2010

Record last verified: 2010-02

Locations

US(1)